Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Author:

Dandona Paresh,Mathieu Chantal,Phillip Moshe,Hansen Lars,Griffen Steven C,Tschöpe Diethelm,Thorén Fredrik,Xu John,Langkilde Anna Maria,Proietto Joseph,Stranks Stephen,Chen Roger,O'Neal David,Pape Alexia,Forbes Mark,Morbey Claire,Luger Anton,Hanusch Ursula,Schnack Christoph,Fliesser-Goerzer Evelyn,Hoelzl Bertram,Ebenbichler Christoph,Prager Rudolf,Van Gaal Luc,Vercammen Chris,Scheen Andre,Mathieu Chantal,Duyck Francis,Nobels Frank,Ruige Johannes,Aggarwal Naresh,Woo Vincent,St-Pierre Bruno,Dumas Richard,Hramiak Irene,Elliott Thomas,Krarup Hansen Troels,Henriksen Jan Erik,Gram Jeppe,Lihn Aina,Bruun Jens,Saltevo Juha,Taurio Jyrki,Strand Jorma,Valle Timo,Nieminen Sakari,Pietilainen Kirsi,Guerci Bruno,Hadjadj Samy,Cariou Bertrand,Verges Bruno,Borot Sophie,Penfornis Alfred,Schaum Thomas,Tschoepe Diethelm,Marck Cornelia,Horacek Thomas,Rose Ludger,Klausmann Gerhard,Luedemann Joerg,Appelt Steffi,Aigner Ulrich,Goebel Rolf,Behnke Thomas,Ziegler Anette-Gabriele,Peterfai Eva,Kerenyi Zsuzsanna,Oroszlan Tamas,Kiss Gyula G.,Konyves Laszlo,Piros Gyorgyi,Phillip Moshe,Mosenzon Ofri,Shehadeh Naim,Adawi Faiad,Wainstein Julio,Dotta Francesco,Piatti Piermarco,Genovese Stefano,Consoli Agostino,Di Bartolo Paolo,Mannucci Edoardo,Giordano Carla,Lapolla Annunziata,Aguilar Carlos,Esteban Alberto,Ruiz Bazzoni,Ramirez Guillermo Mondragon,Pelayo Orozco Emilia,Alejandro Carlos,de Alba Stobschinski,Medina Pech Carlos,Garza Ruiz Jose,Sauque Reyna Leobardo,Llamas Esperon Guillermo,Nevarez Ruiz Luis Alejandro,Vidrio Velazquez Maricela,Flores Lozano Fernando,Gonzalez Gonzalez Jose Gerardo,Garcia-Hernandez Pedro Alberto,Araujo-Silva Roberto,Villeda - Espinosa Efrain,Mistodie Cristina,Popescu Daniela,Constantin Ciprian,Nicolau Alina,Popa Bogdan,Timar Romulus,Serafinceanu Cristian,Pintilei Ella,Soto Alfonso,Gimenez Margarita,Merino-Torres Juan Francisco,Morales Cristobal,Mezquita Pedro,Jendle Johan,Tengmark Bengt-Olov,Eriksson Jan,Londahl Magnus,Eliasson Bjorn,Gunstone Anthony,Heller Simon,Darzy Ken,Mansell Peter,Davies Melanie,Reed Rory,Browne Duncan,Courtney Hamish,Turner Wayne,Blagden Mark,McCrimmon Rory,Bergenstal Richard,Lane Wendy,Lucas Kathryn,White Alexander,Bao Shichun,White Judith,Jantzi Curtis,Rasouli Neda,Ervin William,Lewy-Alterbaum Lorena,Handelsman Yehuda,Miranda-Palma Bresta,Cleland Alan,Fink Raymond,Rodbard Helena,Nakhle Samer,Greenberg Craig,Schorr Alan,Bays Harold,Simmons Debra,Klein Eric,Kane Laurie,Fishman Norman,Ipp Eli,Garg Satish,Bhargava Anuj,Singh Michelle Zaniewski,Rosenstock Julio,Thrasher James,Warren Mark,Young Laura,Aroda Vanita,Pettus Jeremy,Liljenquist David,Busch Robert,Dandona Paresh,Wise Jonathan,Kayne David,Biggs William

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3